• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Recent Advances in the Application of 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid (CAS: 1622883-44-6) in Chemical Biology and Pharmaceutical Research

The compound 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid (CAS: 1622883-44-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic carboxylic acid derivative serves as a crucial building block in the synthesis of novel bioactive molecules, particularly in the design of kinase inhibitors and antimicrobial agents. Recent studies have highlighted its potential in addressing unmet medical needs, making it a focal point for researchers aiming to develop next-generation therapeutics.

One of the most notable applications of 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid is its role in the synthesis of kinase inhibitors. Kinases are pivotal in numerous cellular processes, and their dysregulation is implicated in various diseases, including cancer and inflammatory disorders. Researchers have utilized this compound to develop selective inhibitors targeting specific kinase pathways, thereby minimizing off-target effects. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of derivatives of this compound in inhibiting aberrant kinase activity in non-small cell lung cancer (NSCLC) cell lines, showcasing its potential as a therapeutic agent.

In addition to its applications in oncology, 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid has shown promise in antimicrobial research. The rise of antibiotic-resistant pathogens has necessitated the discovery of novel antimicrobial scaffolds. Recent investigations have revealed that derivatives of this compound exhibit potent activity against multidrug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. These findings underscore its potential as a lead compound for developing new antibiotics to combat the global antimicrobial resistance crisis.

The synthetic versatility of 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid further enhances its appeal in pharmaceutical research. Its structural motifs allow for facile modifications, enabling the generation of diverse chemical libraries for high-throughput screening. A 2022 study in ACS Chemical Biology detailed the use of this compound in the synthesis of a series of analogs with improved pharmacokinetic properties, highlighting its utility in medicinal chemistry optimization. Such advancements are critical for accelerating the drug discovery pipeline and reducing the time-to-market for new therapeutics.

Despite its promising applications, challenges remain in the large-scale synthesis and formulation of 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid-based drugs. Recent efforts have focused on optimizing synthetic routes to enhance yield and purity while minimizing environmental impact. Green chemistry approaches, such as catalytic methods and solvent-free reactions, are being explored to address these challenges. Additionally, computational modeling and structure-activity relationship (SAR) studies are being employed to refine the design of derivatives with enhanced efficacy and safety profiles.

In conclusion, 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid (CAS: 1622883-44-6) represents a valuable scaffold in chemical biology and pharmaceutical research. Its applications in kinase inhibition and antimicrobial therapy, coupled with its synthetic adaptability, position it as a key player in the development of innovative therapeutics. Continued research and collaboration across disciplines will be essential to fully unlock its potential and address the remaining challenges in its clinical translation.

• 1082066-00-9(1-cyclopropylpyrazole-4-carbaldehyde)
• 950858-65-8(1-Tert-butyl-1H-pyrazole-4-carboxylic acid)
• 849612-71-1(1-Propyl-1H-pyrazole-4-carboxylic acid)
• 1103427-25-3(1-(Cyclopropylmethyl)-1H-pyrazole-4-carboxylic acid)
• 1177299-30-7(1-cyclohexyl-1H-pyrazole-4-carboxylic acid)
• 400858-54-0(1-Ethyl-1H-pyrazole-4-carboxylic acid)
• 1006469-47-1(1-(2-Hydroxyethyl)-1H-pyrazole-4-carboxylic acid)
• 436096-96-7(1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid)
• 1006452-51-2(1-Cyclopentyl-1H-Pyrazole-4-Carboxylic acid)
• 1006494-65-0(1-Isobutyl-1H-pyrazole-4-carboxylic Acid)